期刊
INORGANICA CHIMICA ACTA
卷 487, 期 -, 页码 31-40出版社
ELSEVIER SCIENCE SA
DOI: 10.1016/j.ica.2018.11.039
关键词
Cu(II)-complex; Hydrazones; Spectroscopy; Crystal structure; DFT calculations; Anticancer activity
资金
- CONICET of Argentina [PIP 11220130100651CO, PIP 0034]
- UNLP of Argentina [111/X673]
- ANPCyT of Argentina [PICT 2014-2223]
- Consejeria de Educacion CyL [BU076U16, BU022G18]
- FFEDER [BU076U16, BU022G18]
- Ministerio de Economia y Competitividad [CTQ2016-75023-C2-1-P, CTQ2015-70371-REDT]
The new copper complex, [Cu(HL)(OH2)(2)](NO3), including the tridentate N-acyhydrazone derived from 4-hydroxy-benzohydrazide and 2-hydroxy-3-methoxybenzaldehyde, (H2L), has been synthesized and characterized in the solid state and in solution by spectroscopic (FTIR, Ra, UV-vis, EPR) methods. The results were compared with those obtained for the hydrazone ligand and complemented with computational methods based on DFT. The crystal structure of the complex has been determined by X-ray diffraction. It crystallizes in the triclinic P (1) over bar space group with Z = 2. The Cu(II) ion is in a distorted square pyramidal environment, coordinated to a planar HL anion acting as a tridentate ligand. The 5-fold coordination is completed with two water molecules. It is arranged in the lattice as H-bonded ribbon-like polymers that extends along the [1 2 1] crystal direction. The cytotoxicity of the complex together with that of the H2L ligand and the copper ion were evaluated in vitro against five different human cancer cell lines namely A549 (lung), MG-63 (bone), MCF-7 and MDA-MB-231 (breast) and Jurkat (leukemia). The copper complex inhibits the cell viability in a dose dependent manner with a greater potency than the H2L ligand and the free copper ion displaying even higher antitumor activity than the well-known anticancer metallodrug cisplatin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据